Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils.
Isolated trigeminal nerve palsy with motor involvement as a presenting manifestation of multiple sclerosis in an equatorial region - a case report.
Myotonic dystrophy type 2 and multiple sclerosis: Case report.
Immune cell trafficking from the brain maintains CNS immune tolerance.
Interleukin-1β alters glutamate transmission at purkinje cell synapses in a mouse model of multiple sclerosis.
T-cell vaccination in Crohn's disease: principles and presentation of the first two cases.
Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction.
Seeing optic neuritis through myopic eyes.
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
First-line disease-modifying therapies in paediatric multiple sclerosis: a comprehensive overview.
Overview of treatment options in multiple sclerosis.
Oral Agent Outcomes
Effect of laquinimod on MRI-monitored disease activity in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study.
Inhibition of Interferon-beta Responses in Multiple Sclerosis Immune Cells Associated With High-Dose Statins.
Therapeutic protein-drug interaction assessment for daclizumab high-yield process in patients with multiple sclerosis using a cocktail approach.
Impact of Cigarette Smoking on Conversion from Clinically Isolated Syndrome to Clinically Definite Multiple Sclerosis.
Safety and efficacy extension study of daclizumab high yield process (DAC HYP) to treat relapsing remitting multiple sclerosis
Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility.
Individual variability in speed of information processing: An index of cognitive impairment in multiple sclerosis.
Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: a meta-analysis of non-family-based studies.
From injection therapies to natalizumab: views on the treatment of multiple sclerosis.
Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination.
Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system.
Impact of intermittent catheterization on the quality of life of multiple sclerosis patients.
Diffusion Tensor Imaging (DTI) - A New Imaging Technique Applyed in Multiple Sclerosis.

Pages